Indole derivatives as 5-HT1 agonists

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

548181, C07D41314, C07D41714

Patent

active

057171025

ABSTRACT:
Compounds of the formula ##STR1## where A represents a direct bond, C.sub.1 -C.sub.4 alkyl, or C.sub.1 -C.sub.4 alkenyl; n is 0, 1, or 2; R.sub.1 is hydrogen, C.sub.1 -C.sub.6 alkyl, aryl, C.sub.1 -C.sub.3 alkylaryl, C.sub.1 -C.sub.3 alkylheteroaryl, or --(CH.sub.2).sub.m R.sub.6 ; W, X, Y, and Z are each independently oxygen, sulfur, nitrogen or carbon, provided that at least one of W, X, Y or Z is nitrogen; R.sub.2, R.sub.3, R.sub.4, and R.sub.5 are each independently hydrogen, C.sub.1 -C.sub.6 alkyl, aryl, C.sub.1 -C.sub.3 alkylaryl, C.sub.1 -C.sub.3 alkylheteroaryl, halogen, cyano, trifluommethyl, nitro, --OR.sub.7, --NR.sub.7 R.sub.8, --(CH.sub.2).sub.s OR.sub.7, --SR.sub.7, --SO.sub.2 NR.sub.7 R.sub.8, --NR.sub.7 SO.sub.2 R.sub.8, --NR.sub.7 CO.sub.2 R.sub.8, --CONR.sub.7 R.sub.8, or --CO.sub.2 R.sub.7 ; one of R.sub.2 and R.sub.3, R.sub.3 and R.sub.4, or R.sub.4 and R.sub.5 may be taken together to form a five- to seven-membered alkyl ring, a six-membered aryl ring, a five- to seven-membered heteroalkyl ring having 1 heteroatom of N, O, or S, or a five- to six-membered heteroaryl ring having 1 or 2 heteroatoms of N, O, or S; R.sub.6 is cyano, trifluoromethyl, or --OR.sub.9 ; R.sub.7, R.sub.8, and R.sub.9 are each independently hydrogen, C.sub.1 to C.sub.6 alkyl, --(CH.sub.2).sub.m R.sub.10, C.sub.1 to C.sub.3 alkylaryl, or aryl; R.sub.7 and R.sub.8 may be taken together to form a C.sub.4 -C.sub.7 alkyl ring; R.sub.10 is cyano, trifluoromethyl, or C.sub.1 -C.sub.4 alkoxy; R.sub.11 is hydrogen, --OR.sub.12, or --NHCOR.sub.12 ; R.sub.12 is C.sub.1 to C.sub.6 alkyl, aryl, or C.sub.1 to C.sub.3 alkyl-aryl; m is 1, 2, or 3; s is 0, 1, 2, or 3; and the above aryl groups and the aryl moleties of the above alkylaryl groups are independently selected from phenyl and substituted phenyl, wherein said substituted phenyl may be substituted with one to three groups selected from C.sub.1 to C.sub.4 alkyl, halogen, hydroxy, cyano, carboxamido, nitro, and C.sub.1 to C.sub.4 alkoxy, and the pharmaceutically acceptable salts thereof. These compounds are useful psychotherapeutics and are potent serotonin (5-HT.sub.1) agonists and may be used in the treatment of depression, anxiety, eating disorders, obesity, drug abuse, cluster headache, migraine, pain and chronic paroxysmal hemicrania and headache associated with vascular disorders, end other disorders arising from deficient serotonergic neurotransmission. The compounds can also be used as centrally acting antihypertensives and vasodilators.

REFERENCES:
patent: 4252803 (1981-02-01), Webb
patent: 4839377 (1989-06-01), Bays et al.
patent: 4855314 (1989-08-01), Oxford et al.
patent: 5208248 (1993-05-01), Baker et al.
patent: 5298491 (1994-03-01), Chauveau
W. Feniuk, et al., P.P.A. Humphrey & M.J. Perren--Br. J. Pharmacol. (1989), 96, 83-90.
P.P.A. Humphrey, et al.--Br. J. Pharmacol. (1988), 94, 1123-1132.
D. Hoyer, et al., Eur. J. Pharm., 118, 13 (1985).
R. E. Hearing, et al., J. Neuroscience, 7, 894 (1987).
P. Sauerberg, et al., J. Med. Chem., 34, 682 (1991).
G. A. Showell, et al., J. Med. Chem., 34, 1086 (1991).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Indole derivatives as 5-HT1 agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indole derivatives as 5-HT1 agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole derivatives as 5-HT1 agonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2078430

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.